Patrick G. Clay

1.6k total citations
41 papers, 791 citations indexed

About

Patrick G. Clay is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, Patrick G. Clay has authored 41 papers receiving a total of 791 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 11 papers in Epidemiology and 8 papers in Virology. Recurrent topics in Patrick G. Clay's work include HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV Research and Treatment (8 papers). Patrick G. Clay is often cited by papers focused on HIV/AIDS drug development and treatment (15 papers), HIV/AIDS Research and Interventions (14 papers) and HIV Research and Treatment (8 papers). Patrick G. Clay collaborates with scholars based in United States, Japan and United Kingdom. Patrick G. Clay's co-authors include Fabio Vandin, Nasima M. Camp, Benjamin J. Raphael, Eli Upfal, Kathy K. Byrd, Sumihiro Suzuki, Paul J. Weidle, John Hou, Tim Bush and Heather Kirkham and has published in prestigious journals such as SHILAP Revista de lepidopterología, Obstetrics and Gynecology and JAIDS Journal of Acquired Immune Deficiency Syndromes.

In The Last Decade

Patrick G. Clay

40 papers receiving 755 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick G. Clay United States 15 346 183 134 118 117 41 791
R. Chris Rathbun United States 15 424 1.2× 235 1.3× 172 1.3× 101 0.9× 44 0.4× 35 729
Christopher Miller United States 15 328 0.9× 240 1.3× 86 0.6× 57 0.5× 88 0.8× 35 968
Francesca Rocchi Italy 12 144 0.4× 116 0.6× 164 1.2× 133 1.1× 131 1.1× 26 752
Douglas Shaffer United States 14 260 0.8× 186 1.0× 64 0.5× 67 0.6× 104 0.9× 30 774
Jordi Tor Spain 21 364 1.1× 750 4.1× 143 1.1× 101 0.9× 56 0.5× 75 1.2k
S. M. Debanne United States 14 460 1.3× 369 2.0× 146 1.1× 286 2.4× 68 0.6× 18 1.0k
Jacob Levi United Kingdom 12 538 1.6× 267 1.5× 116 0.9× 45 0.4× 105 0.9× 21 761
Christopher McCoy United States 19 137 0.4× 199 1.1× 21 0.2× 78 0.7× 78 0.7× 43 965
S. Herrmann Australia 16 436 1.3× 259 1.4× 308 2.3× 427 3.6× 67 0.6× 40 997
Pablo Ryan Spain 18 478 1.4× 513 2.8× 60 0.4× 98 0.8× 47 0.4× 104 1.1k

Countries citing papers authored by Patrick G. Clay

Since Specialization
Citations

This map shows the geographic impact of Patrick G. Clay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Clay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Clay more than expected).

Fields of papers citing papers by Patrick G. Clay

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick G. Clay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Clay. The network helps show where Patrick G. Clay may publish in the future.

Co-authorship network of co-authors of Patrick G. Clay

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick G. Clay. A scholar is included among the top collaborators of Patrick G. Clay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick G. Clay. Patrick G. Clay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Byrd, Kathy K., Felicia Hardnett, John Hou, et al.. (2020). Improvements in Retention in Care and HIV Viral Suppression Among Persons with HIV and Comorbid Mental Health Conditions: Patient-Centered HIV Care Model. AIDS and Behavior. 24(12). 3522–3532. 16 indexed citations
2.
Shrestha, Ram K., Jon C. Schommer, Michael Taitel, et al.. (2020). Costs and Cost-Effectiveness of the Patient-Centered HIV Care Model: A Collaboration Between Community-Based Pharmacists and Primary Medical Providers. JAIDS Journal of Acquired Immune Deficiency Syndromes. 85(3). e48–e54. 13 indexed citations
3.
Byrd, Kathy K., John Hou, Heather Kirkham, et al.. (2019). Antiretroviral Adherence Level Necessary for HIV Viral Suppression Using Real-World Data. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(3). 245–251. 167 indexed citations
4.
Clay, Patrick G., et al.. (2019). PaCIR: A tool to enhance pharmacist patient care intervention reporting. Journal of the American Pharmacists Association. 59(5). 615–623. 24 indexed citations
5.
Clay, Patrick G., et al.. (2018). A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Research and Therapy. 15(1). 17–17. 44 indexed citations
6.
Clay, Patrick G. & Rustin D. Crutchley. (2014). Noninfectious Diarrhea in HIV Seropositive Individuals: a Review of Prevalence Rates, Etiology, and Management in the Era of Combination Antiretroviral Therapy. Infectious Diseases and Therapy. 3(2). 103–122. 21 indexed citations
7.
Clay, Patrick G.. (2014). SAFETY AND TOLERABILITY OF CROFELEMER 125 MG TWICE DAILY IN THE TREATMENT OF NONINFECTIOUS DIARRHEA IN HIV-SEROPOSITIVE PATIENTS ON ANTIRETROVIRAL THERAPY: RESULTS FROM A PHASE 3, 48-WEEK OPEN-LABEL STUDY. 1 indexed citations
8.
Clay, Patrick G.. (2013). Treatments for cystic fibrosis, increasing solubility and bioavailability, and influenza vaccination dosage. Journal of the American Pharmacists Association. 53(4). 448–448. 1 indexed citations
9.
MacArthur, Rodger D., Trevor Hawkins, Stephen J. Brown, et al.. (2013). Efficacy and Safety of Crofelemer for Noninfectious Diarrhea in HIV-Seropositive Individuals (ADVENT Trial): A Randomized, Double-Blind, Placebo-Controlled, Two-Stage Study. HIV Clinical Trials. 14(6). 261–273. 29 indexed citations
10.
Hicks, Charles B., Patrick G. Clay, Robert Redfield, et al.. (2012). Safety, Tolerability, and Efficacy of KP-1461 as Monotherapy for 124 Days in Antiretroviral-Experienced, HIV Type 1-Infected Subjects. AIDS Research and Human Retroviruses. 29(2). 250–255. 13 indexed citations
11.
Clay, Patrick G., et al.. (2011). Postpartum Pharmacokinetics of Peramivir in the Treatment of 2009 H1N1 Influenza. Obstetrics and Gynecology. 118(2). 463–467. 9 indexed citations
12.
Clay, Patrick G., W. Klugh Kennedy, Mary Jayne Kennedy, et al.. (2010). The Essential Research Curriculum for Doctor of Pharmacy Degree Programs. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(9). 966–966. 47 indexed citations
13.
McRae, MaryPeace, Patrick G. Clay, Peter L. Anderson, & Alan G. Glaros. (2009). Pharmacokinetics of Concurrent Administration of Fosamprenavir and Atazanavir without Ritonavir in Human Immunodeficiency Virus‐Negative Subjects. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(8). 937–942. 1 indexed citations
14.
Clay, Patrick G.. (2008). “One pill, once daily”: what clinicians need to know about Atripla™. Therapeutics and Clinical Risk Management. Volume 4(2). 291–302. 11 indexed citations
15.
Campo, Rafael, S Narayanan, Patrick G. Clay, et al.. (2007). Factors Influencing the Acceptance of Changes in Antiretroviral Therapy among HIV-1–Infected Patients. AIDS Patient Care and STDs. 21(5). 329–338. 6 indexed citations
16.
Clay, Patrick G., et al.. (2007). Costs to Physician Offices of Providing Medications to Medically Indigent Patients Via Pharmaceutical Manufacturer Prescription Assistance Programs. Journal of Managed Care Pharmacy. 13(6). 506–514. 17 indexed citations
17.
18.
Clay, Patrick G.. (2004). Program savings associated with switching testosterone intramuscular injections to topical gel in HIV infected males. Current Medical Research and Opinion. 20(4). 461–468. 2 indexed citations
19.
Clay, Patrick G., Kevin A. Clauson, & Alan G. Glaros. (2004). Complementary and alternative medicine use by patients visiting a free health clinic: A single-site, pilot study. Current Therapeutic Research. 65(6). 481–494. 3 indexed citations
20.
Clay, Patrick G.. (2002). The abacavir hypersensitivity reaction: A review. Clinical Therapeutics. 24(10). 1502–1514. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R. Chris Rathbun Breakdown of academic impact, for papers by Christopher Miller Breakdown of academic impact, for papers by Francesca Rocchi Breakdown of academic impact, for papers by Douglas Shaffer Breakdown of academic impact, for papers by Jordi Tor Breakdown of academic impact, for papers by S. M. Debanne Breakdown of academic impact, for papers by Jacob Levi Breakdown of academic impact, for papers by Christopher McCoy Breakdown of academic impact, for papers by S. Herrmann Breakdown of academic impact, for papers by Pablo Ryan
Rankless by CCL
2026